PARIS -- The early commercial experience with transcatheter aortic valve replacement (TAVR or TAVI) for severe aortic regurgitation appeared promising, though device size issues and conduction ...

November 4, 2011 (Tayside, Scotland) — With growing excitement over the emergence of transcatheter aortic-valve implantation (TAVI), might there still be room for an even less invasive option in ...

A new formula that uses hemodynamic measurements to assess aortic regurgitation during transcatheter aortic valve replacement (TAVR) can better predict 1-year mortality than echocardiography alone, ...

Atrial fibrillation (AF) was present in 1 in 6 patients with chronic aortic regurgitation — either moderate-to-severe or severe — and was independently associated with an increased risk for mortality ...

Patients who underwent transcatheter aortic valve replacement (TAVR) with a valve designed to treat aortic regurgitation had an overall mortality rate of just 8.1% at one year, well below the trial's ...

WASHINGTON, DC—There’s fresh evidence that off-label use of TAVR devices for pure native aortic valve regurgitation (NAVR) is associated with “not optimal” outcomes, although newer-generation devices, ...

NEW ORLEANS, LA—The use of ACE inhibitors for patients with moderate to severe aortic regurgitation (AR) was associated with improved mortality and cardiovascular (CV) outcomes, according to the ...

Aortic valve disease is a condition that occurs when your aorta (the main artery of your body) and left ventricle (the lower left chamber of your heart) malfunction. The aortic valve determines how ...

What is responsible for the myriad physical examination findings in patients with severe aortic regurgitation, including pulsation of multiple organs? When will the murmur of aortic valve ...

Aortic insufficiency is a potentially severe condition that affects the heart’s ability to pump blood. There are many possible causes for this condition. Aortic insufficiency is a form of heart valve ...